People who refused to get vaccinated against COVID-19 had low levels of social trust, weak attachments to the rule of law, and were less willing to honor collective commitments to the greater good, according to Cornell research published today.
Targeting part of a key antiviral pathway may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.
Working with physicians at Weill Cornell Medicine and therapists at the Cayuga Medical Center, Cornell Hybrid Body Lab researchers have devised a knitted wearable technology that can ease discomfort caused by hand edema.
The Sloan Program in Health Administration in the Cornell Jeb E. Brooks School of Public Policy has once again been ranked among the best in the nation. The new U.S. News rankings have the program rising to the No. 8 spot.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
The Cornell Center for Health Equity has launched its racial allyship training course, providing anyone who wants to learn to be a better ally with essential skills and tools they can use in their personal and professional lives.
Researchers have identified blood biomarkers that could help pediatricians quickly diagnose severe cases of COVID-19 as well as multisystem inflammatory syndrome, also known as MIS-C, which emerged during the pandemic.
Pauline Flaum-Dunoyer has interviewed more than a dozen women physicians of color, and donated the recordings and transcripts to NewYork-Presbyterian/Weill Cornell Medicine, where their legacies will be preserved for future generations.
